4 Results for "

GSK256066

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "GSK256066" in MCE Product Catalog:

  • Targets Recommended:
2
2 Cited Publications
Cat. No.: HY-10469
CAS No.: 801312-28-7
Purity:  98.69%
Research Areas:  

Inflammation/Immunology

GSK256066 is a selective and high-affinity phosphodiesterase 4 (PDE4) inhibitor, with an IC50 of 3.2 pM for PDE4B. GSK256066 is developed for the research of chronic obstructive pulmonary disease .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-70069
CAS No.: 1415560-64-3
Research Areas:  

Inflammation/Immunology

GSK256066 Trifluoroacetate is a selective and high-affinity phosphodiesterase 4 (PDE) inhibitor, with an IC50 of 3.2 pM for PDE4B. GSK256066 Trifluoroacetate is developed for the research of chronic obstructive pulmonary disease .
loading...
    loading...
Cat. No.: HY-10469R
CAS No.: 801312-28-7
GSK256066 (Standard) is the analytical standard of GSK256066. This product is intended for research and analytical applications. GSK256066 is a selective and high-affinity phosphodiesterase 4 (PDE4) inhibitor, with an IC50 of 3.2 pM for PDE4B. GSK256066 is developed for the research of chronic obstructive pulmonary disease .
loading...
    loading...
Cat. No.: HY-70069R
CAS No.: 1415560-64-3
Research Areas:  

Inflammation/Immunology

GSK256066 (Trifluoroacetate) (Standard) is the analytical standard of GSK256066 (Trifluoroacetate). This product is intended for research and analytical applications. GSK256066 Trifluoroacetate is a selective and high-affinity phosphodiesterase 4 (PDE) inhibitor, with an IC50 of 3.2 pM for PDE4B. GSK256066 Trifluoroacetate is developed for the research of chronic obstructive pulmonary disease .
loading...
    loading...